Risk Factors for Potential Drug -Drug Interactions: Study in Surgical Intensive Care Unit -Zagazig University Hospitals.
NCT04078620 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 120
Last updated 2019-09-06
Summary
Drug drug interactions is frequent in critically ill patients due to polypharmacy, different drug groups and prolonged ICU or hospital stay
Conditions
- Drug Interaction
Interventions
- DIAGNOSTIC_TEST
-
Survey for drug drug interactions on medscape and lexicomp applications
Survey for drug drug interactions on Medscape and Lexicomp interaction checker applications
Sponsors & Collaborators
-
Zagazig University
lead OTHER_GOV
Principal Investigators
-
Liza Shallouf · Zagazig University
-
Heba Matar · Zagazig University
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2018-06-15
- Primary Completion
- 2019-01-15
- Completion
- 2019-04-20
Countries
- Egypt
Study Locations
More Related Trials
-
Drug to Drug Interaction Study With Ipragliflozin and Furosemide
NCT01611415 ·Status: COMPLETED ·Phase: PHASE1
-
A Drug-drug Interaction Study Between GLPG1205 and a Cocktail of CYP450 Substrates in Healthy Male Subjects
NCT02623296 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate Drug-drug Interactions Between BR1017-1 and BR1017-2 in Healthy Volunteers
NCT05372380 ·Status: COMPLETED ·Phase: PHASE1
-
Dabigatran in an Interaction Probe Drug Cocktail
NCT02361619 ·Status: COMPLETED ·Phase: PHASE1
-
Drug-drug Interaction Study Between UIC201601 and UIC201602
NCT05190133 ·Status: COMPLETED ·Phase: PHASE1
-
Drug-Drug Interaction of Cardizem LA (Diltiazem Hydrochloride) on Pitavastatin
NCT01422382 ·Status: COMPLETED ·Phase: PHASE4
-
Drug-drug Interactions Between DWC202211 and DWC202212 in Healthy Subjects
NCT05699070 ·Status: UNKNOWN ·Phase: PHASE1
-
A Drug-Drug Interaction Study of Diltiazem and MK-1167 in Healthy Adult Participants (MK-1167-006)
NCT06703463 ·Status: COMPLETED ·Phase: PHASE1
-
Phase 1 Drug Interaction Study of the Effect of Apixaban on the PK of Digoxin in Healthy Subjects
NCT02262520 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Investigate the Drug-drug Interactions (DDIs) Between SKLB1028 and Midazolam in Healthy Subjects
NCT05070195 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate the Effect of AMG 510 on the Pharmacokinetics (PK) of Digoxin in Healthy Participants
NCT05598281 ·Status: COMPLETED ·Phase: PHASE1
-
Drug-drug Interaction Study With GLPG3667 and Midazolam in Healthy Subjects
NCT04736927 ·Status: COMPLETED ·Phase: PHASE1
-
Drug-Drug Interaction (DDI) Study in Healthy Volunteers
NCT04814498 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Investigate Drug-Drug Interaction Between D326, D337 and CKD-828 in Healthy Subjects
NCT03726866 ·Status: UNKNOWN ·Phase: PHASE1
-
A Study to Assess Drug-drug Interaction of ZX008 in Healthy Male and Female Study Participants
NCT06679413 ·Status: COMPLETED ·Phase: PHASE1
-
Study of the Effect of Dapagliflozin on the Pharmacokinetics of Warfarin or Digoxin in Healthy Subjects
NCT00904176 ·Status: COMPLETED ·Phase: PHASE1
-
Drug-Drug Interaction Study With AGMB-129 and Midazolam in Healthy Participants
NCT05937386 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of the Interaction of Other Drugs With TAK-279 in Healthy Adults
NCT06290050 ·Status: COMPLETED ·Phase: PHASE1
-
Drug-Drug Interaction Study Between TAK-272 and Itraconazole, Digoxin or Midazolam
NCT02370615 ·Status: COMPLETED ·Phase: PHASE1
-
A Open-Label Drug-Drug Interaction Study of Telotristat Etiprate and Midazolam in Healthy Subjects
NCT02147808 ·Status: COMPLETED ·Phase: PHASE1
-
Transporter Cocktail Mutual Interaction
NCT02854527 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Investigate Drug-Drug Interaction Between MT-7117 and Test Drugs in Healthy Subjects
NCT04793295 ·Status: COMPLETED ·Phase: PHASE1
-
Digoxin Drug-Drug Interaction With Lurasidone HCl
NCT01082289 ·Status: COMPLETED ·Phase: PHASE1
-
Drug-Drug Interaction Study to Evaluate the Effect of Inhibition of UGTs on the PK of Ecopipam and Its Active Metabolite
NCT04902105 ·Status: COMPLETED ·Phase: PHASE1
-
Drug-durg Interaction of SHR3680 With Digoxin, Rosuvastatin Calcium and Metformin Hydrochloride
NCT04621669 ·Status: UNKNOWN ·Phase: PHASE1